Cost-effectiveness evaluation of linezolid, vancomycin and teicoplanin in treating nosocomial pneumonia caused by methicilin resistant staphylococcus aureus (mrsa) – Public health care system perspective
May 1, 2013, 00:00
10.1016/j.jval.2013.03.431
https://www.valueinhealthjournal.com/article/S1098-3015(13)00502-0/fulltext
Title :
Cost-effectiveness evaluation of linezolid, vancomycin and teicoplanin in treating nosocomial pneumonia caused by methicilin resistant staphylococcus aureus (mrsa) – Public health care system perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00502-0&doi=10.1016/j.jval.2013.03.431
First page :
A92
Section Title :
Infection
Open access? :
No
Section Order :
1478